Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
EventHumanPharmacovigilance

Swedish is available via eTranslation, the European Commission's machine translation service.

Translate to Swedish | Important information about machine translation

Datum

måndag, 5 februari 2024, Hela dagen
torsdag, 8 februari 2024, Hela dagen

Plats

European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the PRAC meeting 5-8 February 2024

Draft Reference Number: EMA/PRAC/11237/2024 Corr.1

English (EN) (529.37 KB - PDF)

Först publicerad: Senast uppdaterad:
Visa

Minutes of the PRAC meeting 5-8 February 2024

Adopted Reference Number: EMA/PRAC/122241/2024

English (EN) (875.86 KB - PDF)

Först publicerad:
Visa

Share this page